DTIC AD1008700: Trial of Naltrexone and Dextromethorphan pdf

DTIC AD1008700: Trial of Naltrexone and Dextromethorphan

More Book Details

Description of the Book:

This research study aims to expand the field of knowledge of Gulf War Illness. The research may provide initial proof of the innovative hypothesis that Gulf War Illness is related to low grade neuron-inflammation, which can be down regulated, by Naltrexone and Dextromethorphan. This is untested but potentially groundbreaking concept that could provide, both an enhanced understanding of, and beneficial treatment for, Gulf War Illnesses. Research at the National Institute of Environmental Health and other facilities has proven that naltrexone and dextromethorphan reduce inflammation in the brain. Clinical trials in humans with low Dextromethorphan have established benefits in syndromes related to Gulf War Illness such as fibromyalgia. We have successfully enrolled 41 subjects in the study, and anticipate obtaining important data by the end of the coming year. A no cost extension has been obtained to complete the study

• Creator/s: Defense Technical Information Center
• Date: 7/1/2015
• Year: 2015
• Book Topics/Themes: DTIC Archive, Meggs, William J, EAST CAROLINA UNIV GREENVILLE NC GREENVILLE United States, CHEMICAL REACTIONS, INFLAMMATION, central nervous system

An excerpt captured from the PDF book